Literature DB >> 11201564

Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).

A O Oluoch1, C H Kim, R M Weisiger, H Y Koo, A M Siegel, K L Campbell, T J Burke, B C McKiernan, I Kakoma.   

Abstract

OBJECTIVE: To determine nonenteric sites associated with Escherichia coli isolates in dogs and the antimicrobial susceptibilities of the isolates.
DESIGN: Retrospective study. SAMPLE POPULATION: 17,000 canine specimens. PROCEDURE: Medical records of 17,000 canine specimens submitted for bacteriologic culture were examined and the number of isolations of E coli was determined. For these cases, records were further examined with respect to body system involvement, sex, concurrent infection with other species of bacteria, and antimicrobial susceptibility.
RESULTS: 674 E coli isolates (424 from urine, 62 from the skin, 52 from the respiratory tract, 45 from the ear, 43 from the female reproductive tract, 25 from the male reproductive tract, and 23 from other organ systems) were identified. There was a significantly higher proportion of isolates from urine specimens from spayed females than from sexually intact females or males. Escherichia coli was isolated in pure culture from 65.9% of the specimens. Most E coli isolates were susceptible to norfloxacin (90%), enrofloxacin (87.5%), gentamicin (90.7%), and amikacin (85.9%). CONCLUSIONS AND CLINICAL RELEVANCE: Most nonenteric E coli infections in dogs involve the urinary tract. Amikacin, gentamicin, norfloxacin, and enrofloxacin have the highest efficacy against canine E coli isolates. For E coli isolates from dogs, in vitro susceptibility to commonly used antimicrobial agents has remained fairly stable during the past decade.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201564     DOI: 10.2460/javma.2001.218.381

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Antimicrobial activity and spectrum of cefovecin, a new extended- spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America.

Authors:  M R Stegemann; C A Passmore; J Sherington; C J Lindeman; G Papp; D J Weigel; T L Skogerboe
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Antimicrobial resistance trends among canine Escherichia coli isolates obtained from clinical samples in the northeastern USA, 2004-2011.

Authors:  Kevin J Cummings; Victor A Aprea; Craig Altier
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

Review 3.  An Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli Infections.

Authors:  Erin J Breland; Allison R Eberly; Maria Hadjifrangiskou
Journal:  Front Cell Infect Microbiol       Date:  2017-05-09       Impact factor: 5.293

4.  Antimicrobial susceptibility and risk factors for resistance among Escherichia coli isolated from canine specimens submitted to a diagnostic laboratory in Indiana, 2010-2019.

Authors:  John E Ekakoro; G Kenitra Hendrix; Lynn F Guptill; Audrey Ruple
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

5.  Microbiological and histopathological aspects of canine pyometra.

Authors:  Jennifer Anne Coggan; Priscilla Anne Melville; Clair Motos de Oliveira; Marcelo Faustino; Andréa Micke Moreno; Nilson Roberti Benites
Journal:  Braz J Microbiol       Date:  2008-09-01       Impact factor: 2.476

6.  Characterisation of bacterial growth and antimicrobial susceptibility patterns in canine urinary tract infections.

Authors:  Ulrika Windahl; Bodil Ström Holst; Ann Nyman; Ulrika Grönlund; Björn Bengtsson
Journal:  BMC Vet Res       Date:  2014-09-24       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.